Masong, Fernando P.
HRN: 21-65-14 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2022
CEFTRIAXONE 1G (VIAL)
07/27/2022
08/02/2022
IV
2g
Q12
CAP-MR; Brain Abcess
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes